Geron to Present at the H.C. Wainwright Global Investment Conference
September 09 2020 - 9:00AM
Business Wire
Geron Corporation (Nasdaq: GERN), a late-stage clinical
biopharmaceutical company, today announced that John A. Scarlett,
M.D., Chairman and Chief Executive Officer, will present a company
overview at the H.C. Wainwright 22nd Annual Global Investment
Conference, to be hosted in a virtual format, on Monday, September
14, 2020 at 2:30 p.m. ET.
A live audio webcast of the presentation will be available on
Geron’s website, www.geron.com/investors/events. If you are unable
to listen to the live presentation, an archived webcast will be
available on the Company’s website for 30 days.
About Geron
Geron is a late-stage clinical biopharmaceutical company focused
on the development and potential commercialization of a
first-in-class telomerase inhibitor, imetelstat, in hematologic
myeloid malignancies. For more information about Geron, visit
www.geron.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200909005329/en/
Suzanne Messere Investor and Media Relations investor@geron.com
media@geron.com
Geron (NASDAQ:GERN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Geron (NASDAQ:GERN)
Historical Stock Chart
From Apr 2023 to Apr 2024